Citigroup’s Zymergen Inc. Common Stock ZY Stock Holding History

Citigroup’s Portfolio ZY Stock Details ZY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-139,642	Closed	-$388K	–	6189
2022 Q3	$388K	Sell	139,642 -82,289	-37%	-$200K	﹤0.01%	3421
2022 Q2	$273K	Sell	221,931 -593,813	-73%	-$996K	﹤0.01%	3659
2022 Q1	$2.36M	Buy	815,744 +795,528	+3,935%	+$3.38M	﹤0.01%	2235
2021 Q4	$135K	Buy	20,216 +18,083	+848%	+$176K	﹤0.01%	4574
2021 Q3	$28K	Buy	2,133 +895	+72%	+$19K	﹤0.01%	5077
2021 Q2	$50K	Buy	+1,238	New	+$48.9K	﹤0.01%	4831

Citigroup's ZY Position: Q4 2022 in Review

Citigroup sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 139,642 shares — an estimated $388K sold.

Citigroup first reported a position in ZY in Q2 2021 and held it in 6 quarters. The position peaked at $2.36M in Q1 2022. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

Citigroup reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Citigroup sold 139,642 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $388K.
Citigroup first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 6 quarters.
Citigroup's Zymergen Inc. Common Stock position peaked at $2.36M in Q1 2022.
0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Citigroup's 13F filing for Q4 2022, filed 9 Feb 2023.